Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst

Microbes and Infection

Volumn 13, Issue 5, 2011, Pages 457-467

  Sangalli Leite, Fernanda ^a,b   Scorzoni, Liliana ^a,b   Mesa Arango, Ana Cecilia ^a,c   Casas, Celia ^d   Herrero, Enrique ^d   Soares Mendes Gianinni, Maria José ^b   Rodríguez Tudela, Juan Luis ^a   Cuenca Estrella, Manuel ^a   Zaragoza, Oscar ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^d UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Amphotericin B; Cryptococcus neoformans; Oxidative burst; Propidium iodide; XTT

Indexed keywords

AMPHOTERICIN B; FREE RADICAL;

ANTIFUNGAL ACTIVITY; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG EFFECT; FLUORESCENCE MICROSCOPY; FUNGUS GROWTH; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; YEAST CELL;

FILOBASIDIELLA NEOFORMANS;

EID: 79953278557     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.01.015     Document Type: Article

References (36)

1. Oura M., Sternberg T.H., Wright E.T. A new antifungal antibiotic, amphotericin B. Antibiot. Annu. 1955, 3:566-573.
2. Ellis D. Amphotericin B: spectrum and resistance. J. Antimicrob. Chemother. 2002, 49(Suppl. 1):7-10.
3. Rodriguez Tudela J.L., Diaz-Guerra T.M., Mellado E., Cano V., Tapia C., Perkins A., Gomez-Lopez A., Rodero L., Cuenca-Estrella M. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob. Agents Chemother. 2005, 49:4026-4034.
4. Sutton D.A., Sanche S.E., Revankar S.G., Fothergill A.W., Rinaldi M.G. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J. Clin. Microbiol. 1999, 37:2343-2345.
5. Baginski M., Sternal K., Czub J., Borowski E. Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic. Acta Biochim. Pol. 2005, 52:655-658.
6. Fera M.T., La Camera E., De Sarro A. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Expert Rev. Anti. Infect. Ther. 2009, 7:981-998.
7. Sucher A.J., Chahine E.B., Balcer H.E. Echinocandins: the newest class of antifungals. Ann. Pharmacother. 2009, 43:1647-1657.
8. Dromer F., Mathoulin-Pelissier S., Launay O., Lortholary O. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med. 2007, 4. e21.
9. Lortholary O., Poizat G., Zeller V., Neuville S., Boibieux A., Alvarez M., Dellamonica P., Botterel F., Dromer F., Chene G.H., Group T.F.C.S. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS 2006, 20:2183-2191.
10. Park B.I., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
11. Perfect J.R., Dismukes W.E., Dromer F., Goldman D.L., Graybill J.R., Hamill R.J., Harrison T., Larsen R.A., Lortholary O., Nguyen M.H., Pappas P.G., Powderly W.G., Singh N., Sobel J.D., Sorrell T.C. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2010, 50:291-322.
12. Gomez-Lopez A., Zaragoza O., Rodriguez-Tudela J.L., Cuenca-Estrella M. Pharmacotherapy of yeast infections. Expert Opin. Pharmacother. 2008, 9:2801-2816.
13. Perkins J.A., Gomez-Lopez A., Mellado E., Rodriguez Tudela J.L., Cuenca-Estrella M. Rates of antifungal resistance among Spanish clinical isolates neoformans var. neoformans. J. Antimicrob. Chemother. 2005, 56:1144-1147.
14. Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties?. Biochim. Biophys. Acta 1986, 864:257-304.
15. Lamy-Freund M.T., Ferreira V.F., Schreier S. Mechanism of inactivation of the polyene antibiotic amphotericin B. Evidence for radical formation in the process of autooxidation. J. Antibiot (Tokyo) 1985, 38:753-757.
16. Sokol-Anderson M., Sligh J.E.J., Elberg S., Brajtburg J., Kobayashi G.S., Medoff G. Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B. Antimicrob. Agents Chemother. 1988, 32:702-705.
17. Roehm N.W., Rodgers G.H., Hatfield S.M., Glasebrook A.L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods 1991, 142:257-265.
18. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., Currens M.J., Seniff D., Boyd M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988, 48:4827-4833.
19. Jacobs D.B., Pipho C. Use of propidium iodide staining and flow cytometry to measure anti-mediated cytotoxicity: resolution of complement-sensitive and resistant target cells. J. Immunol. Methods 1991, 62:101-108.
20. Perfect J.R., Lang S.D.R., Durack D.T. Chronic cryptococcal meningitis: a new experimental model in rabbits. Am. J. Pathol. 1980, 101:177-194.
21. Kwon-Chung K.J. Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia 1976, 68:821-833.
22. Zaragoza O., Chrisman C.J., Castelli M.V., Frases S., Cuenca-Estrella M., Rodriguez-Tudela J.L., Casadevall A. Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell Microbiol. 2008, 10:2043-2057.
23. Molina M.M., Belli G., de la Torre M.A., Rodriguez-Manzaneque M.T., Herrero E. Nuclear monothiol glutaredoxins of Saccharomyces cerevisiae can function as mitochondrial glutaredoxins. J. Biol. Chem. 2004, 279:51923-51930.
24. Cabiscol E., Piulats E., Echave P., Herrero E., Ros J. Oxidative stress promotes specific protein damage in Saccharomyces cerevisiae. J. Biol. Chem. 2000, 275:27393-27398.
25. Chen W.C., Chou D.L., Feingold D.S. Dissociation between ion permeability and the lethal action of polyene antibiotics on Candida albicans. Antimicrob. Agents Chemother. 1978, 13:914-917.
26. Palacios D.S., Anderson T.M., Burker M.D. A post-PKS oxidation of the amphotericin B skeleton predicted to be critical for the channel formation is not required for potent antifungal activity. J. Am. Chem. Soc. 2007, 129:13804-13805.
27. Phillips A.J., Sudbery P., Ramsdale M. Apoptosis induced by environmental stresses and amphotericin B in Candida albicans. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14327-14332.
28. Sokol-Anderson M., Brajtburg J., Medoff G. Amphotericin B-induced oxidative damage and killing of Candida albicans. J. Infect. Dis. 1986, 154:76-83.
29. Blum G., Perkhofer S., Haas H., Schrettl M., Wurzner R., Dierich M.P., Lass-Florl C. Potential basis for Amphotericin B resistance in Aspergillus terreus. Antimicrob. Agents Chemother. 2008, 52:1553-1555.
30. Brajtburg J., Elberg S., Kobayashi G.S., Medoff G. Effects of ascorbic acid on the antifungal action of amphotericin B. J. Antimicrob. Chemother. 1989, 24:333-337.
31. Liao R.S., Rennie R.P., Talbot J.A. Sublethal injury and resuscitation of Candida albicans after amphotericin B treatment. Antimicrob. Agents Chemother. 2003, 47:1200-1206.
32. Mowat E., Lang S., Williams C., McCulloch E., Jone B., Ramage G. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms. J. Antimicrob. Chemother. 2008, 62:1281-1284.
33. Barwicz J., Gruda I., Tancrede P. A kinetic study of the oxidation effects of amphotericin B on human low-density lipoproteins. FEBS Lett. 2000, 465:83-86.
34. Brajtburg J., Powderly W.G., Kobayashi G.S., Medoff G. Amphotericin B: current understanding of mechanisms of action. Antimicrob. Agents Chemother. 1990, 34:183-188.
35. Barwicz J., Dumont I., Ouellet C., Gruda I. Amphotericin B toxicity as related to the formation of oxidatively modified low-density lipoproteins. Biospectroscopy 1998, 4:135-144.
36. 2 stress-induced apoptosis-like events in Cryptococcus neoformans. Res. Microbiol. 2008, 159:628-634.